Clinical Trial: HS-IT101 Injection in the Treatment of Advanced Melanoma(FASTIL-Mela01)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Advanced Melanoma
Study Type: INTERVENTIONAL
Official Title: Single Arm, Phase I Clinical Study of HS-IT101 Injection in the Treatment of Advanced Melanoma
Brief Summary:
Single-arm, open-label,interventional study evaluating adoptive cell therapy (ACT) with autologous tumor-infiltrating lymphocyte (TIL) infusion (HS-IT101) after lymphodepletion preparative with fludarabine and cyclophosphamide regimen, followed by IL-2, for the treatment of patients with advanced melanoma.
Read more